Released on: January 23, 2008, 3:45 pm

Press Release Author: Four infectious diseases experts will discuss the future of
infectious disease therapeutics at the 5th Anti-Infectives Partnering & Deal-Making
Summit taking place on March 5-7, 2008 in Philadelphia, PA.

Industry: Pharmaceuticals

Press Release Summary: MONROVIA, CA - Four infectious diseases experts will discuss
the future of infectious disease therapeutics at the 5th Anti-Infectives Partnering
& Deal-Making Summit taking place on March 5-7, 2008 in Philadelphia, PA.



Press Release Body: MONROVIA, CA - Four infectious diseases experts will discuss the
future of infectious disease therapeutics at the 5th Anti-Infectives Partnering &
Deal-Making Summit taking place on March 5-7, 2008 in Philadelphia, PA.

Roger M. Echols, Chief Medical Officer for Replidyne, will moderate a forty-five
minutes panel entitled, "Future of Infectious Disease Therapeutics". He will be
joined by panelists Mike Fuller at Knobbe Martens Olson & Bear; Dennis Molnar, Vice
President of Corporate Development for Paratek Pharmaceuticals; and Michael Dudley,
Vice President of Drug Development for MPEX Pharmaceuticals.

Other topics to be covered at the 5th Anti-Infectives Partnering & Deal-Making
Summit include New Anti-Infectives Technologies, Current Models of R&D
Collaboration, New Pathogen Challenges, VC Investment Opportunities in the
Anti-Infectives Space, and Developing Partnerships with Big Pharma.

Meet and hear presentations from experts of leading organizations such as
AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Global Alliance for TB
Drug Development, GlaxoSmithKline, Human Genome Sciences, Merck, Novartis, Wyeth,
and many more. The full agenda is available online at www.gtcbio.com.

The 5th Anti-Infectives Partnering & Deal Making Summit is an infectious disease
partnering and business development conference that gives global biotechnology and
pharmaceutical companies an opportunity to network with high-level executives from
top pharma and various biotech/pharmaceutical companies, as well as explore
potential collaborations, and learn about relevant anti-infective issues and deals
that affect the industry.

This event also provides a unique venue for attendees to learn about the
anti-infective business development trends, the infectious disease markets, and
novel technologies that shape up the industry. For more information, please visit
www.gtcbio.com.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com



Web Site: http://www.gtcbio.com

Contact Details: GTCbio
434 W Foothill Blvd.
Monrovia, CA 91016